<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[fda and pharmaceutical company Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/fda+and+pharmaceutical+company.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to fda and pharmaceutical company]]></description>
	<s:counts start="0" returned="20" found="147" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Big Pharma's Facebook Fail]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005698/big-pharmas-facebook-fail/]]></link>
		<description><![CDATA[UCB Pharma (UCB.BR) has an Epilepsy Facebook page that doesn't mention it's published by UCB. And AstraZeneca AZN has a page for Nexium that does not let visitors post messages on its Wall. Adweek revisits the long-established phenom of drug companies not liking social media in case patients start telling...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 07 Dec 2009 12:57:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/facebook.html"><![CDATA[Facebook]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/web+2.0.html"><![CDATA[Web 2.0]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Seeks Advice From Blogger; Google Solves Pharma's Ad Problems]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005281/fda-seeks-advice-from-blogger-google-solves-pharmas-ad-problems/]]></link>
		<description><![CDATA[The FDA sought the advice of John Mack, a blogger with 20,000 monthly readers who runs the Pharma Marketing Blog, on how drug companies should use the web to advertise their products. The agency usually likes to hear from lawyers, drug company executives and academics when it seeks regulatory advice....]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 12 Nov 2009 15:08:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/google+inc..html"><![CDATA[Google Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/advice.html"><![CDATA[Advice]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/blogger.html"><![CDATA[Blogger]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
		<category domain="tickers">GOOG</category>
	</item>
	<item>
		<title><![CDATA[Vanda Vaults From Dog House to Drug Approval]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002022/vanda-vaults-from-dog-stock-to-drug-approval/]]></link>
		<description><![CDATA[IfÂ there was one biotech on every banker's list of cash shells, one dog that could make bankruptcy look like a good option, one name synonymous with snickers and snide comments,Â it was Vanda Pharmaceuticals. Which makes the FDA's approval of Vanda's schizophrenia drug Fanapt iloperidone surprising, to say the least. ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 08 May 2009 13:30:46 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/vanda.html"><![CDATA[Vanda]]></category>
		<category domain="http://resources.bnet.com/topic/fanapt.html"><![CDATA[Fanapt]]></category>
		<category domain="http://resources.bnet.com/topic/street.html"><![CDATA[Street]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Boehringer Ingelheim and 8 Other Companies Caught Selling Illegal Painkillers]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001558/boehringer-ingelheim-and-8-other-companies-caught-selling-illegal-painkillers/]]></link>
		<description><![CDATA[The FDA has banned Boehringer Ingelheim and eight other drug companies from selling illegal, unapproved pain drugs.    The drugs removed from the market include high concentrate morphine sulfate oral solutions, hydromorphone and oxycodone. The FDA:  "Consumers have a right to expect that their drugs meet the...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 01 Apr 2009 12:28:57 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/roxicodone.html"><![CDATA[Roxicodone]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000547/drug-makers-gave-lobbyists-an-xmas-gift-millions-more-to-lobby-obama-administration/]]></link>
		<description><![CDATA[A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 31 Dec 2008 11:36:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/administration.html"><![CDATA[Administration]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/biotech+drug.html"><![CDATA[Biotech Drug]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Medicis Solves One Solodyn Problem But Barr Pops Up With Another]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000544/medicis-solves-one-solodyn-problem-but-barr-pops-up-with-another/]]></link>
		<description><![CDATA[Barr Pharmaceuticals has filed to make a generic version of Medicis's acne drug, Solodyn. Medicis stock had received a nice boost at the beginning of December when it announced an unexpected deal with a different company, Impax, over generic versions of Solodyn.    The deal meant Medicis would...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 30 Dec 2008 12:08:26 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/medicis.html"><![CDATA[Medicis]]></category>
		<category domain="http://resources.bnet.com/topic/barr.html"><![CDATA[Barr]]></category>
		<category domain="http://resources.bnet.com/topic/solodyn.html"><![CDATA[Solodyn]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Wyeth Restructures, Anti-Pharma Activist at FDA, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000347/pharma-roundup-wyeth-restructures-anti-pharma-activist-at-fda-and-more/]]></link>
		<description><![CDATA[Wyeth restructures R&D, FDA appointee may cause problems for pharma, BIO launches site to dispute TV show. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 28 Oct 2008 17:48:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cbs+corp..html"><![CDATA[CBS Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">CBS,WYE</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Glaxo Wins Most Ethical, FDA Lacks Committee Leadership, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000335/pharma-roundup-glaxo-wins-most-ethical-fda-lacks-committee-leadership-and-more/]]></link>
		<description><![CDATA[GlaxoSmithKline tops ethics rankings, three out of four FDA advisory committees lack permanent leadership, great expectations lead to failed pharma alliances, Europe delays pharma bill. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 24 Oct 2008 16:58:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/ethics.html"><![CDATA[Ethics]]></category>
		<category domain="http://resources.bnet.com/topic/business+ethics.html"><![CDATA[Business Ethics]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Profitability of Cancer Research Questioned, "Voluntary" Label Change Suggested by FDA, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000287/pharma-roundup-profitability-of-cancer-research-questioned-voluntary-label-change-suggested-by-fda-and-more/]]></link>
		<description><![CDATA[Is there money in cancer research? Also, "voluntary" label change came from FDA; Abbott Labs repurchasing $5 billion in stock. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 13 Oct 2008 16:36:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/businessweek.html"><![CDATA[BusinessWeek]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
	</item>
	<item>
		<title><![CDATA[Can Pharma Survive DTC Ad Restrictions?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100075/can-pharma-survive-dtc-ad-restrictions/]]></link>
		<description><![CDATA[The rise of the modern pharmaceutical industry is closely intertwined with the advent of "direct-to-consumer" advertising -- those ubiquitous TV and magazine ads for antidepressants, sleep aids, erectile-dysfunction drugs and a whole slew of other treatments.    In fact, it's hard to imagine how the industry could ever...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 20 May 2008 02:41:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/tv.html"><![CDATA[TV]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[Collegium Pharmaceutical Announces FDA Filing for AllerNase&#153;, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_8/ai_n25129787]]></link>
		<description><![CDATA[CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company with a focus on respiratory and CNS disorders, today announced that it filed a Supplemental New Drug Application sNDA with the U.S. Federal Drug Administration FDA for the approval of AllerNase[TM] (triamcinolone acetonide, USP) Nasal Spray, 50 mcg, an aqueous...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Helsinn and MGI Pharma Announce sNDA for Aloxi Capsules Accepted for Review by U.S. FDA.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200801/ai_n23678597]]></link>
		<description><![CDATA[LUGANO, Switzerland, January 3 /PRNewswire/ --     Helsinn  Healthcare S.A., Switzerland, a privately owned pharmaceutical  group  and its partner, MGI Pharma (Nasdaq: MOGN), a biopharmaceutical  company  focused in oncology and acute care, today announ  LUGANO, Switzerland, January 3 /PRNewswire/ -- ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Collegium Pharmaceutical to Advance its Allergic Rhinitis Product into Phase III Trials]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_17/ai_n21157488]]></link>
		<description><![CDATA[CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it plans to proceed with its Phase III clinical program to evaluate COL 118, its novel modified release combination antihistamine for the treatment of allergic rhinitis. This is following a meeting with the U.S. Food and Drug...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ProEthic Pharmaceuticals Announces Acceptance of New Drug Application for Migraine]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_12/ai_n27473378]]></link>
		<description><![CDATA[MONTGOMERY, Ala. -- ProEthic Pharmaceuticals, Inc., a privately funded specialty pharmaceutical company that acquires, develops, licenses and markets niche prescription products, announced today that the U.S. Food and Drug Administration FDA has accepted the Company's submission of its New Drug Application for PRO-513 for the treatment of migraine headaches. In...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Bioxel Pharma Inc.: Second-Quarter 2007 Results; Bioxel Continues to Set the Stage for its Growth by Registering its Docetaxel with the FDA and Health Canada and Expanding its Commercial Footprint in Europe.(Financial report)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200708/ai_n22564490]]></link>
		<description><![CDATA[SAINTE-FOY, QUEBEC, Aug 20, 2007 CCNMatthews via COMTEX -- Bioxel  Pharma Inc. (TSX VENTURE:BIP), a leading manufacturer of taxane active  pharmaceutical ingredients APIs and developer of targeted oncology  drugs, today announced its results for the  SAINTE-FOY, QUEBEC, Aug 20, 2007 CCNMatthews via COMTEX -- Bioxel ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 20 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Axcan Pharma Submits Complete New Drug Application for ULTRASE.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200708/ai_n22563462]]></link>
		<description><![CDATA[MONT-SAINT-HILAIRE, QUEBEC, Aug 2, 2007 CCNMatthews via COMTEX --  Axcan Pharma Inc. ("Axcan" or the "Company")  (TSX:AXP)(NASDAQ:AXCA) today announced that it has submitted the  complete New Drug Application ("NDA") for   MONT-SAINT-HILAIRE, QUEBEC, Aug 2, 2007 CCNMatthews via COMTEX --  Axcan Pharma Inc. ("Axcan" or...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 02 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Collegium Pharmaceutical Inc. Announces FDA Acceptance of IND for its Abuse Deterrent Sustained Release Opioid Product]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_12/ai_n27303318]]></link>
		<description><![CDATA[CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Investigational New Drug Application ("IND") for its patent pending, abuse deterrent, sustained release, oral opioid formulation COL-003 is now active following its acceptance by the U.S. Food and Drug Administration FDA. The Company submitted the IND...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Axcan Pharma Submits CMC Portion of its New Drug Application for ULTRASE and is Granted Fast Track Status.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200706/ai_n22559677]]></link>
		<description><![CDATA[MONT-SAINT-HILAIRE, QUEBEC, Jun 21, 2007 CCNMatthews via COMTEX  -- Axcan Pharma Inc. ("Axcan" or the "Company")  (TSX:AXP)(NASDAQ:AXCA) today announced that it has filed the Chemistry,  Manufacturing and Control data ("CMC&qu  MONT-SAINT-HILAIRE, QUEBEC, Jun 21, 2007 CCNMatthews via COMTEX  -- Axcan Pharma Inc. ("Axcan" or the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Collegium Pharmaceutical Inc., Announces the Filing of IND for Abuse Deterrent Sustained Release Opioid Product]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_15/ai_n27275463]]></link>
		<description><![CDATA[CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug ("IND") for its patent pending abuse deterrent sustained release opioid formulation COL-003. This follows a pre-IND meeting that the Company held with the FDA in March 2007 at which time...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Jun 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Novagali Pharma Receives US FDA Orphan Drug Designation for Vekacia(R) for the Treatment of Vernal Keratoconjunctivitis.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200705/ai_n23625837]]></link>
		<description><![CDATA[EVRY, France, May 25 /PRNewswire/ --     Novagali Pharma, an  emerging ophthalmic pharmaceutical company, announced today orphan drug  designation granted by the U.S. Food and Drug Administration FDA to  Cyclosporine A drug VekaciaR, a patented cati  EVRY, France, May 25 /PRNewswire/ -- ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 25 May 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/designation.html"><![CDATA[designation]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
